Identification of Molecular Subtypes and Prognostic Traits Based on Chromosomal Instability Phenotype-Related Genes in Lung Adenocarcinoma
Lung adenocarcinoma (LUAD) exhibits significant molecular heterogeneity; however, previous studies have not fully explored its classification into distinct molecular subtypes. Here, we identified LUAD-significant chromosomal instability (CIN) phenotype genes (<i>n</i> = 24) using a TCGA-LUAD cohort (<i>n</i> = 592) and evaluated their ability to predict pathologic grade. Unsupervised clustering and principal component analysis revealed that LUAD patients could be classified into CIN phenotype-related subtypes (Group<sup>Low</sup>, Group<sup>Moderate</sup>, and Group<sup>High</sup>), each exhibiting distinct transcriptomic patterns. Notably, the Group<sup>High</sup> showed significantly poor overall survival [OS; hazard ratio (HR) = 1.43, <i>p</i>-value < 10<sup>-3</sup>] and disease-free survival (DFS; HR = 1.27, <i>p</i>-value < 10<sup>-3</sup>). Univariate and multivariate analysis confirmed that its expression status was an independent prognostic predictor (<i>p</i>-value < 10<sup>-3</sup>, HR = 2.18, 95% C.I = 1.26-3.76) of the clinical outcomes, outperforming pathologic grade (<i>p</i>-value < 10<sup>-3</sup>, HR = 1.2, 95% C.I = 1.08-1.33). Moreover, analysis of surfactant metabolism-related genes revealed higher expression in the Group<sup>Low</sup>, which was associated with a favorable prognosis. By integrating multiple independent cohorts (<i>n</i> = 779), we validated these findings and confirmed that CIN phenotype gene status serves as a critical prognostic marker in LUAD. Furthermore, genomic profiling showed that the Group<sup>High</sup> exhibited frequent mutations in key genes such as <i>KEAP1</i>, <i>LYST</i>, <i>SETD2</i>, and <i>TP53</i>, with oncogenes in this group preferentially showing copy number gains. Our study highlights the significance of CIN phenotype gene status as a predictor of LUAD prognosis and its association with transcriptomic and genomic alterations, paving the way for further clinical validation and potential therapeutic interventions.
Authors
- Youngsic Jeon (ORCID: https://orcid.org/0000-0002-5673-5036)
- Kyung‐Chul Choi (ORCID: https://orcid.org/0000-0001-9449-6163)
- Young Nyun Park (ORCID: https://orcid.org/0000-0003-0357-7967)
- Young‐Joo Kim (ORCID: https://orcid.org/0000-0003-1080-0581)
Institutions
- Ulsan College (KR)
- Yonsei University (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
- Korea Institute of Science and Technology (KR)
Publication Details
- Journal
- Cancers
- Published
- 2024-11-13
- DOI
- https://doi.org/10.3390/cancers16223818
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Korea Institute of Science and Technology